LLM BreastGPT; px engagement. ViewFinder; unique helping doctors read 3D X-Rays to diagnose breast cancer. USA & UK. FDA approved.
Elaitra has raised $761K in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2023.
Elaitra's investors include SFC Capital, Cancer Research Horizons, KCP Capital.
Elaitra is headquartered in San Francisco, United States.
LLM BreastGPT; px engagement. ViewFinder; unique helping doctors read 3D X-Rays to diagnose breast cancer. USA & UK. FDA approved.
Elaitra is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elaitra — Funding & Investors." VCBacked, June 30, 2023, https://www.vcbacked.co/company/elaitra. Accessed July 19, 2026.
VCBacked. (2023). Elaitra — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/elaitra
{{cite web |title=Elaitra — Funding & Investors |url=https://www.vcbacked.co/company/elaitra |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated